Aerosol treatment is the approach used to manage the drugs immediately into the lungs and their airlines. It is mostly a suspension of beverages or solids administered the usage of a scientific device which includes an inhaler.
The aerosol treatment market growth is driven by the increasing prevalence of chronic respiratory conditions such as COPD, asthma, and pneumonia, the main advantage of the aerosol treatment is the usage of smaller doses, giving rapid response with minimal side effects. The diversified use of aerosol treatment to treat different indications and additional therapeutic effects is driving the growth of the aerosol treatment market.
The increasing prevalence of chronic respiratory diseases is expected to drive the growth in the forecast period
The major respiratory disorders currently cured using aerosol treatment include Asthma, COPD, Bronchiectasis, cystic fibrosis, pulmonary arterial hypertension, and infectious pulmonary diseases. As per the Center for Disease Control and Prevention (CDC), around 16 million people suffer from COPD. As per CDC, in the last decade, the prevalence of asthma in the U.S. has increased by 15%. For example, 3.8 million people in Canada had asthma, and 2.0 million had chronic obstructive pulmonary disease (COPD) in 2018. Respiratory diseases also lead to lost productivity and healthcare costs. The increasing burden of these diseases needs rapid intervention by increasing better treatment.
Side-effects associated with aerosol treatment is likely to hinder the market growth
A few reported adverse cases of oral candidiasis in patients who use aerosol treatment may hamper the growth of the market.
North America region holds the largest market share of the global aerosol treatment market
North America region is dominating the global aerosol treatment market accounted for the largest market share. As the population in the region follows a fast-moving lifestyle, patients are looking for more inhalers that can be transferred easily in a time of need for patients suffering from asthma and other airway diseases.
In addition, healthcare cost containment issues, the post-economic crises in the United States, have required the government to introduce new strategies to reduce patient stays in hospitals. This provided the impetus to homecare services, which in turn, created a favorable environment for the growth of the aerosol treatment market.
Competitive Landscape
The global aerosol treatment market is highly competitive with the presence of global companies. Some of the key players which are contributing to the growth of the market include Merck, Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Novartis, Teva Pharmaceuticals, Opko Health, Omron Healthcare, Medtronic, GE Healthcare. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
